Keratins MNF116 and CAM5.2, epithelial membrane antigen (EMA), CD31
, and CD34 were also negative, as was CAMTA1, a recently described antibody expressed in epithelioid hemangioendothelioma (Table 1 and Fig.
Image-Pro Plus 6.0 was used to determine the mean optical density of CD31
expression in the lung.
EV origin Surface markers Endothelium [CD31.sup.+]/[CD41.sup.-]([PECAM.sup.+]/[ITGA2B.sup.-]) [CD31.sup.+]/[CD42.sup.-] ([PECAM.sup.+]/[GPIb.sup.-]) CD31
(PECAM (platelet cell adhesion molecule)) CD144 (VE cadherin (vascular endothelial cadherin)) CD146 (MCAM (melanoma cell adhesion molecule)) CD105 (endoglin) CD106 (VCAM (vascular cell adhesion molecule)) CD62E (E-selectin (endothelial-selectin)) Platelet CD41 (ITGA2B (integrin alpha 2b)) CD42 (GPIb (glycoprotein Ib)) CD31
(PECAM (platelet cell adhesion molecule)) Leukocyte CD45 (PTPRC (protein tyrosine phosphate receptor type C)) CD11b (ITGAM (integrin alpha M)) CD14 (coreceptor of lipopolysaccharide) CD16 (on surface of neutrophils, monocytes, and macrophages) CD62L (L-selectin (leukocyte selectin)) Red blood cell CD235 (glycophorin A)
A consult was made, an additional staining including Cam 5.2, CD31
, and ERG.
The purpose of this study was to analyse the ability to integrate bone substitutes by evaluating the IHC expression of the platelet endothelial cell adhesion molecules (PECAM-1/ Cd31
), VEGF, collagen IV, laminin, and osteonectin for the three materials used for augmentation: bovine hydroxyapatite, beta-tricalcium phosphate, and bioactive glasses.
The aim of this study was to evaluate VEGF-A expression and MVD through expression of CD31
in endothelial cells in aggressive lymphomas such as DLBCL, in indolent lymphomas such as FL, and in lymph node reactive follicular hyperplasia (FH).
Hence, scarce data are available on the immunohistomorphology of microvascular ECs for CD34 and the expression of CEPCs for commonly used EC markers like CD31
, CD34, CD45 and CD133 in the pancreas tissue in a diabetic rat, in comparison with that of the kidneys and liver.
Antibodies against the following proteins were purchased from Abcam (Cambridge, MA, USA): alpha smooth muscle actin ([alpha]-SMA) (#ab7817), TGF-beta 1 (#ab66043), and CD31
CD90 (Biolegend, USA), CD45 (Biolegend, USA), CD44 (Biolegend, USA), and CD31
(Affymetrix eBioscience, USA) were used to identify the surface marker of BMSCs.
After 2 weeks, MSC survival was determined by GFP fluorescence, and differentiation was determined by performing immunofluorescence assays of CD31
Immunohistochemistry of the following panel was performed: podoplanin (D2-40 as antibody, commonly known as a marker of lymphatic endothelial cells), CD31
(known as a marker of pan-endothelial cells), CD68 (a marker of macrophages/ histiocytes), smooth muscle actin (SMA; a marker of smooth muscle differentiation), and WT1 and calretinin (common markers of mesothelial cells).
We performed CD31
(i.e., panendothelialmarker) and CD105 (i.e., proliferating endothelium marker) immunostaining on samples of 70 SCCs and 70 BCCs of the skin.